AKT1 and neoplasm: Later studies using other tumour models revealed that A3R activation resulted in downregulation of the cAMP-dependent PI3K/AKT axis and ERK1/2 kinase [81], nuclear transcription factor-κB (NF-κB), and the Wnt/β-catenin pathway [82].